* Health and Medical News:Endo to buy Par Pharmaceuticals for $8.05B

"This will position us as a top-five generics player in the U.S.," Endo International CEO Rajiv De Silva says.

from @ Health and Medical News http://ift.tt/1EfqGx9
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...

Popular Health News